Skip to content

Stepan

US · SCL #3013 by market cap Listed 1970
61.32 -1.07 -1.72%
Live - 5344 symbols - heartbeat 129s ago · 2026-10-08 05:31
Pre-market 60.80 -0.85%
After-hours 61.32 0.00%
Market cap
1.39B
P/E (TTM)
-511.00
P/B
1.15
EPS
2.05
Reader sentiment Are you bullish or bearish on SCL?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 1.17 Cheap vs history 31st percentile
5-year average 1.55 · #12 of 56 in Specialty Chemicals
P/E ratio -519.92 Cheap vs history 3rd percentile
5-year average -0.59 · forward 24.08
P/S ratio 0.58 Cheap vs history 26th percentile
5-year average 0.75 · forward 0.54 · #11 of 61 in Specialty Chemicals

Vs. peers Specialty Chemicals

Company Market cap P/E (TTM) P/B Div yield
Stepan (SCL) 1.39B -511.00 1.15 2.56%
Linde (LIN) 223.11B 31.22 5.71 1.28%
Ecolab (ECL) 77.96B 37.33 7.75 1.02%
Sherwin-Williams (SHW) 76.47B 29.06 19.84 1.01%
Air Products & Chemicals (APD) 61.93B -1,324.38 4.46 2.59%
PPG Industries (PPG) 23.36B 15.03 2.77 2.70%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value72.14 Economic moatNone UncertaintyLow

Trading 17.7% below Morningstar's fair value estimate.

Fair value

Stepan Co receives a 5-star quantitative star rating, reflecting our opinion that this share class offers a compelling opportunity for investors. The stock currently trades at a 14% discount to our quantitative fair value estimate of $72.14 per share, which is reinforced by this estimate's low uncertainty rating.

The company's valuation metrics bolster our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 84.6%, which lies in the top 40% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are cheap.

Alternatively, the firm's lack of profitability is potentially concerning. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's earnings yield of 3.3%, a core component of profitability, falls in the bottom 45% compared with global peers. The earnings generated by the company relative to its share price is concerning, which, despite our favorable price/fair value ratio, is a negative attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 05:31:08 · For reference only, not investment advice and not tailored to your situation.